Related Experiment Videos

[A case of amyopathic dermatomyositis with rapidly progressive interstitial pneumonia]

Y Nanke1, M Tateisi, H Yamagata

  • 1Department of Internal Medicine, National Murayama Hospital, Tokyo.

Ryumachi. [Rheumatism]
|October 6, 2000
PubMed

Insights

This case study details a fatal instance of interstitial pneumonia (IP) linked to amyopathic dermatomyositis (DM). KL-6 levels showed promise as a sensitive marker for interstitial pneumonia activity in this patient.

Area of Science:

  • Rheumatology
  • Pulmonology
  • Clinical Medicine

Background:

  • Amyopathic dermatomyositis (DM) is an autoimmune condition characterized by skin manifestations without significant muscle weakness.
  • Interstitial pneumonia (IP) can be a severe complication of DM, significantly impacting prognosis.

Observation:

  • A 53-year-old male presented with fever, polyarthritis, and characteristic skin lesions (heliotrope eruption, Gottron's sign) but no myositis symptoms.
  • Normal serum creatine kinase (CK) levels and electromyography (EMG) ruled out overt myositis.
  • Chest CT revealed bilateral interstitial pneumonia at the lung bases.

Findings:

  • The patient was diagnosed with amyopathic DM complicated by IP.
  • Standard treatments including methylprednisolone and oral prednisolone were ineffective for the rapidly progressing IP.
  • Cyclophosphamide showed transient benefit, while cyclosporine A was ineffective.
  • The patient ultimately succumbed to respiratory failure.

Implications:

  • This case highlights the critical association between amyopathic DM and interstitial pneumonia.
  • KL-6 emerged as a potentially sensitive biomarker for monitoring IP activity in this context.
  • The limited treatment response underscores the aggressive nature of IP in some amyopathic DM cases.

Related Concept Videos